HIMSS TV is your Insider’s Guide to everything HIMSS. We are the world’s first online broadcasting network, focused on global innovation and how information and technology are driving change in healthcare.
  Home
Now is the time to prep for future pandemics
Digital Checkup

Now is the time to prep for future pandemics

8:17

Machine learning can help flag troubling patterns and improve systems moving forward, says Linguamatics' Dr. Elizabeth Marshall.

Read More
Read Less

Digital Checkup - Similar Videos View more in Digital Checkup

5:16

Ukraine's Aspichi studies VR for mental resilience

Viktor Samoilenko, CEO and founder of Aspichi, describes how the Ukraine-based mixed reality company is using immersive technologies to address mental health challenges and build resilience with evidence-based psychological approaches.

Ukraine's Aspichi studies VR for mental resilience
Viktor Samoilenko, CEO and founder of Aspichi, describes how the Ukraine-based mixed reality company is using immersive technologies to address mental health challenges and build resilience with evidence-based psychological approaches.
5:16
5:31

Using ambient documentation to track disease spread

With ongoing Ebola outbreaks in the Democratic Republic of Congo and Uganda, Ian Shakil, chief strategy officer at Commure, discusses the potential role of ambient AI documentation in infectious disease surveillance and outbreak response.

Using ambient documentation to track disease spread
With ongoing Ebola outbreaks in the Democratic Republic of Congo and Uganda, Ian Shakil, chief strategy officer at Commure, discusses the potential role of ambient AI documentation in infectious disease surveillance and outbreak response.
5:31
4:00

Toby on its urine-based cancer detection test

Matthew Laskowski, CEO of Toby, discusses the machine learning and biomarker analysis technology behind the company’s urine-based multi-cancer detection test that has received FDA Breakthrough Device designation in the United States.

Toby on its urine-based cancer detection test
Matthew Laskowski, CEO of Toby, discusses the machine learning and biomarker analysis technology behind the company’s urine-based multi-cancer detection test that has received FDA Breakthrough Device designation in the United States.
4:00